Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice
Cancer Medicine · 2024
DOI: 10.1002/cam4.70362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Piero Bettoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Salvage Therapy, Prostate-Specific Antigen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose and Objective Salvage radiotherapy (sRT) can have similar outcomes to adjuvant radiotherapy (aRT) if administered at the earliest evidence of biochemical recurrence. RADICALS‐RT was the first trial to support this hypothesis and a policy of observation after radical prostatectomy (RP) with early sRT has become the new standard of care since then. This study assessed the impact of RADICALS‐RT in the clinical practice regarding the timing of sRT for prostate cancer initially treated with RP.
Methods
Data from 297 patients who underwent sRT after radical RP were retrospectively collected. Two groups were created and analyzed on the basis of the date of RADICALS‐RT presentation at ESMO. After these results were released in October 2021, our institutional postoperative radiotherapy policy was revisited, and a third group was created and analyzed separately.
Results
Median PSA for Groups 1, 2, and 3 were 0.33, 0.27, and 0.2, respectively. Less than one‐third of patients in Groups 1 and 2 had a postoperative PSA of 0.2 ng/mL or less at the time of sRT. Group 3 showed statistically significant differences in median PSA at the time of sRT compared with Groups 1 and 2.
Conclusions
RADICALS‐RT demonstrated a significant impact on clinical practice only after being complemented with real local evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.
- Department of Cancer Research, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.
- Department of Digital Health and Medical Informatics, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.
ORCID-Profile: Piero Bettoli
Zitieren
APA
Bettoli, P., Röling, E., Russo, M., Sánchez, M. F., Paredes, I., & Sapunar, J. (2024). Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice. Cancer Medicine. https://doi.org/10.1002/cam4.70362
Vancouver
Bettoli P, Röling E, Russo M, Sánchez MF, Paredes I, Sapunar J. Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice. Cancer Medicine. 2024. doi:10.1002/cam4.70362
BibTeX
@article{Bettoli2024,
author = {Bettoli, Piero and Röling, Evangelina and Russo, Moises and Sánchez, María Fernanda and Paredes, Inti and Sapunar, Jorge},
title = {Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70362}
}
EUVIMED